TERIFLUNOMIDE (TERIFLUNOMIDE) — FDA Approval ANDA209702 (SOMERSET THERAPS LLC)
TERIFLUNOMIDE (TERIFLUNOMIDE) — FDA Approval ANDA209702 (SOMERSET THERAPS LLC) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: TERIFLUNOMIDE; Active ingredients: TERIFLUNOMIDE; Application number: ANDA209702.
| Brand name | TERIFLUNOMIDE |
|---|---|
| Active ingredients | TERIFLUNOMIDE |
| Application number | ANDA209702 |
| Sponsor | SOMERSET THERAPS LLC |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 2 |
| First approval date | 20200228 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →